Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare

It will be difficult to compare Moderna, Inc. and Pfizer Inc.’s coronavirus vaccines based on their Phase 3 study designs, some vaccines experts said.

“Both trials appeared to be well designed,”... Read more »

Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients

Fast enrollment of the right patient populations will be critical to quickly conducting Phase III trials of COVID-19 vaccines and this will likely mean taking concerted steps to reach out to... Read more »

Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives

The US Health and Human Services agency isn’t ready to go all in on “pull” incentives to encourage the development of new antibiotics, the agency indicated in response to a new... Read more »